Dr. Marconi earned a bachelor of science degree from William Patterson College and PhD from the University of Montana studying microbiology and biophysical chemistry, respectively. After completing his PhD work, he began his post-doctoral training at the Roche Institute of Molecular Biology where he studied bacterial metabolism. His postdoctoral studies continued at the Rocky Mountain Laboratories, an NIH research facility, where he began working on Lyme disease and other tick-borne diseases. Dr. Marconi joined VCU Medical Center in 1994 and is now a Full Professor of Medicine.
Dr. Marconi has 30 years of experience studying spirochetal and tick borne diseases including Lyme disease, Anaplasmosis, Ehrlichiosis, tick-borne relapsing fever, periodontal disease and leptospirosis. He has lectured worldwide, published over 110 research articles and served on over 100 national and international advisory panels. He was a chartered member of the Vaccines for Microbial Diseases NIH Study Section and currently serves on several Scientific Advisory and editorial boards. In 2016 he received the Billy Martin Innovation award for his Lyme disease vaccine work. He is an inventor of VANGUARD crLYME and the Global Lyme Diagnostic assay and is credited for the development of an innovative vaccine and diagnostic antigen technology called “Chimeritope Technology”. Currently, he is working aggressively to develop diagnostic assays, vaccines and new therapeutic strategies for human Lyme disease, anaplasmosis and other important bacterial diseases of human and veterinary concern.